The self-assembly of Ab to b-sheet-rich neurotoxic oligomers is a main pathological event leading to Alzheimer's disease (AD). Selective targeting of Ab oligomers without affecting other functional proteins is therefore an attractive approach to prevent the disease and its progression. In this study, we report that photodynamic treatment of Ab in the presence of catalytic amounts of chlorin e6 can selectively damage Ab and inhibit its aggregation and toxicity. Chlorin e6 also reversed the amyloid aggregation process in the dark by binding its soluble and low molecular weight oligomers, as shown by thioflavin T (ThT) fluorescence and photoinduced cross-linking of unmodified protein (PICUP) methods. Using HSQC NMR spectroscopy, ThT assays, amino acid analysis, SDS/PAGE, and EPR spectroscopy, we show that catalytic amounts of photoexcited chlorin e6 selectively damage the Ab histidine residues H6, H13, and H14, and induce Ab cross-linking by generating singlet oxygen. In contrast, photoexcited chlorin e6 was unable to cross-link ubiquitin and a-synuclein, demonstrating its high selectivity for Ab. By binding to the Ab histidine residues, catalytic amounts of chlorin e6 can also inhibit the Cu 2+ -induced aggregation and toxicity in darkness, while at stoichiometric amounts it acts as a chelator to reduce the amount of free Cu
Introduction
Misfolding of proteins and their subsequent aggregation to cross b-sheet conformation are the hallmark of more than thirty different devastating diseases, including many neurodegenerative and peripheral diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases and type II diabetes. Among these diseases, Alzheimer's disease (AD) is the most prevalent neurodegenerative disease with approximately 35 million people diagnosed worldwide. The neuropathology of AD is characterized by two types of lesions -senile plaques and neurobrillary tangles (NFTs). The NFTs are composed of aberrantly phosphorylated tau, while the plaques consist mainly of aggregates of b-amyloid (Ab) -a 39-43-amino acid protein generated from enzymatic degradation of the amyloid precursor protein (APP).
1
The self-assembly and aggregation of Ab to form soluble oligomers and brils are strongly associated with the onset of the disease, where the soluble oligomers are believed to be the most toxic species to the neurons.
2 Although the exact mechanism by which Ab oligomers cause neurotoxicity is still under scientic debate, specic targeting of toxic Ab oligomers has shown promising therapeutic results.
3 During the past two decades, numerous approaches have been envisioned and adopted to reduce the amount of Ab in AD patients and to inhibit Ab aggregation and accumulation.
2b,4
These efforts include the development of b-and g-secretase inhibitors that target the production of Ab from APP, anti-Ab immunotherapy, chelation therapy, and b-sheet blockers that inhibit the oligomerization of soluble Ab. However, none of these approaches has been approved yet for clinical application, mainly due to nonspecic effects of the agents on other important biological targets.
Since many misfolded proteins have important biological activities in their correctly folded conformations, selective targeting of the specic protein at its pathological site might reduce systemic toxicity and increase patient safety. Photodynamic therapy (PDT) has been used for decades in cancer therapy and different skin diseases to improve drug selectivity. oxygen ( 1 O 2 ). ROS and especially HO radicals are very powerful oxidizing agents that can oxidize and degrade biopolymers such as DNA and proteins. The free radicals have a very short halflife, and are therefore most effective along a path of <15Å.
6
Oxidation of amino acid residues in proteins leads to generation of cross-linked aggregates, cleavage of the polypeptide chain, and modications of the proteins and peptide fragments. 7 Thus, a system generating ROS at well-dened loci should be capable of producing targeted local damage at the subcellular and/or molecular level. Selective damage at the subcellular level could be easily achieved via a focused light source of suitable wavelength and a corresponding photosensitizer. Superior selectivity could further be achieved through conjugation of the photosensitizer to vectors that bind with high affinity and selectivity to an over-expressed protein or biomolecule on the cell surface.
8
We and others have recently demonstrated that photoirradiation of Ab in the presence of a photosensitizer dramatically attenuates its aggregation and toxicity in vitro as well as in a Drosophila model.
9 To further increase the specicity and selectivity, the photosensitizers were cleverly conjugated to an Ab binding peptide such as KLVFF.
9c,f,g Nevertheless, conjugation of a photosensitizer to a targeting peptide may alter its pharmacokinetics and bioavailability, such as the blood-brain barrier permeability, highlighting the need for more selective photosensitizers. Moreover, little attention has been given to the interactions between the photosensitizers and Ab at a molecular level and the mechanism by which they attenuate Ab aggregation under light and dark conditions.
In this study, we demonstrate that the photosensitizer chlorin e6 (Ce6) binds Ab 40 with high affinity and selectivity, and show that the ability of Ce6 to inhibit Ab's aggregation and toxicity signicantly increases upon illumination with light. We also studied the mechanism by which Ce6 selectively inhibits Ab aggregation and toxicity, and explored molecular-level modes of interaction between Ce6 and Ab. Ce6 and its derivatives are well known for their biochemical and biophysical properties and photo-induced antitumor activity.
10 Unlike porphyrins with 22 p electrons and 4 pyrroles, chlorins are characterized by 20 p electrons at their cores that are composed of three pyrroles and one pyrroline bridged by four sp 2 hybridized carbon atoms without the presence of a metal (Scheme S1 †). It has minimal dark toxicity, high stability and solubility in injectable solutions, and exhibits a high quantum yield of singlet molecular oxygen production.
11 An injectable formulation of a Ce6-polyvinylpyrrolidone complex (Photolon®), was reported to easily cross the intact blood-brain barrier in rats and accumulate in tissues of the central nervous system, 12 while mono-L-aspartyl Ce6 was approved in Japan in 2003 as a PDT agent for treatment of lung cancer.
13

Results and discussion
Anti-aggregation activity of Ce6 under dark and light conditions
We used a uorescent titration experiment and the thioavin T (ThT) assay to examine the association of Ce6 with Ab and its ability to inhibit Ab amyloid aggregation. The binding constant between Ce6 and Ab and number of the binding sites were determined according to Bose et al. 14 Addition of increasing concentrations of Ce6 (1-100 mM) to a constant concentration of Ab (50 mM) dose-dependently quenched the Ab uorescence at 316 nm (excitation at 280 nm, Fig. S1a †) . 14 The uorescence studies also provided a binding constant of 5.5 mM between Ce6 and Ab and the number of binding sites of 0.995 (Fig. S1c †) . The antiamyloidogenic activity of Ce6 was determined by exposing monomeric Ab to increasing concentrations of Ce6 for 1 h in the dark, followed by exposure to visible light. Samples kept in the dark were used as controls. The extent of Ab aggregation was then determined aer 72 h incubation using ThT uorescence in which a large increase in uorescence is generated upon binding of ThT to cross b-sheet structures. 15 While incubation of Ab with Ce6 in the dark dose-dependently decreased the ThT uorescence intensity of the samples (EC 50 ¼ 2 mM), incubation following visible light exposure signicantly increased the antiamyloidogenic potency of Ce6 (EC 50 ¼ 0.4 mM; Fig. 1a ).
We also used circular dichroism (CD) spectroscopy to study the effect of Ce6 on the structural transformation of Ab from random coil to b-sheet, both in the dark and aer photoirradiation ( Fig. 1b and c) . Aging of monomeric Ab for 72 h changed its conformation from random coil, characterized by a negative peak at 198 nm (Fig. 1b) , to b-sheet conformation with a positive band around 198 nm and a negative band at 222 nm (Fig. 1c) . Presence of an equimolar concentration of Ce6 in the mixture under dark conditions did not signicantly affect this transition. In contrast, incubation of the Ab/Ce6 mixture under photoirradiation conditions generated a distinct CD signal, which was very different from that of a b-sheet. Ce6 did not produce any CD signal by its own, and photoirradiation of Ab alone had no signicant effect on its structural transformation (Fig. 1c) . These results indicate that photoexcited Ce6 prevents Ab aggregation by inhibiting its structural transition to a b-sheet conformation.
The strong antiamyloidogenic activity of Ce6 under photoirradiation was conrmed by TEM, using the Ab samples from the ThT assay. We found that aging of Ab (20 mM) alone and in the presence of Ce6 (2 mM) generated well-dened brils under dark conditions. In contrast, aging of the Ab and Ce6 mixtures under light generated aggregates that were morphologically different and signicantly shorter (Fig. 1d) .
Photoexcited Ce6 decreases the amount of Ab toxic oligomers and disassembles aggregated Ab Next, we tested whether photoexcited Ce6 can modulate the selfassembly of Ab to generate toxic oligomers, using a dot blot assay and the oligomer-specic polyclonal antibody A11. This conformational antibody was raised against oligomeric Ab species and was found to reduce their toxicity. 16 Aging of Ab (20 mM) in darkness for 72 h, with or without Ce6 (20 mM), generated A11-reactive aggregates. This shows that stoichiometric amount of Ce6 has a small effect on Ab oligomerization under dark conditions. In stark contrast, photoirradiation of the Ab-Ce6 mixture dramatically reduced its reactivity to A11 (Fig. 1e) . Interestingly, under light conditions Ce6 completely inhibits binding of the 6E10 antibody to both Ab monomers (t ¼ 0 h) and Ab oligomers (t ¼ 72 h), with some effect also on the Ab oligomers under dark conditions (Fig. 1e) . As the 6E10 antibody binds to the N-terminal Ab1-17 segment, 17 these results indicate that Ce6 also binds to this segment.
Having demonstrated that Ce6 strongly binds to Ab ( Fig. 1a and S1 †), we examined whether it can disassemble aggregated or brillar Ab under dark as well as light conditions. Ab40 was aged for three days to generate aggregates and brils with strong ThT uorescence signal. The aggregated Ab was then incubated with Ce6 for 1 h, either in darkness or under light irradiation. The amount of remaining aggregated Ab was then determined by ThT assay aer 72 h of incubation. Under dark conditions, Ce6 dose-dependently disaggregated the Ab aggregates. However, disaggregation of Ab aggregates by Ce6 under light conditions was observed only for higher Ce6 concentration (50 mM; Fig. 2a) . Surprisingly, at low concentration, photoexcited Ce6 caused a signicantly stronger ThT uorescent signal than that obtained in the absence of Ce6 or at the higher Ce6 concentration, possibly suggesting that photoirradiation of Ab aggregates in the presence of small amounts of Ce6 (10%) generates greater amounts of ThT-active Ab species (Fig. 2a) . However, although ThT uorescence intensity is oen used to quantify the amount of amyloid material present in a solution, it is nonlinear and depends on other factors including solvent and the presence of additional small molecules -in particular those that interact with Ab.
Effect of Ce6 on Ab oligomer distribution under dark and light conditions
In order to shed light on the mechanism by which Ce6 affects Ab aggregation under dark and light conditions, its effect on Ab oligomer distribution was determined using the photoinduced cross-linking of unmodied proteins (PICUP) method.
7b,19
Under dark conditions and in the absence of Ce6, freshly prepared Ab maintains a dynamic equilibrium between several oligomeric species, with monomers as the most abundant species (Fig. 2b, lane 1) . Following the aging process, a timedependent decrease in the amounts of Ab monomers and small oligomers (2-5-mers) was evident (Fig. 2b, lanes 1-3) . The presence of Ce6 in the mixture stabilized the 1-3-mers (Fig. 2b , lanes 4-6), suggesting that binding of Ce6 to Ab monomers and early soluble oligomers is responsible for the reduced aggregation and possible disaggregation of Ab brils, most probably by shiing the equilibrium toward the small, soluble oligomers (Fig. 2b) .
20
The effect of Ce6 on the oligomer distribution was also tested under light conditions. Monomeric Ab was incubated without or with Ce6, photoirradiated for 1 min, and analyzed with SDS-PAGE under the same conditions used in the PICUP analysis. Interestingly, photoirradiation of Ab in the presence of Ce6 but in the absence of Ru 2+ , which was used as a crosslinker in the PICUP experiments, also generated SDS-stable cross-linked oligomers very similar to those generated in the presence of Ru 2+ (Fig. 2c ). Since the cross-linking mechanism of the Ru 2+ complex involves photo-generation of radical intermediates, 7b these results suggest that photo-induced cross-linking might be the mechanism by which Ce6 inhibits aggregation of Ab into toxic oligomers. It has previously been shown that metalloporphyrins mediate cross-linking of proteins upon photoirradiation, and this effect is in part responsible for their mode of action in photodynamic therapy (PDT).
Molecular mechanism of Ab cross-linking by photoexcited Ce6
The cross-linking of Ab by Ce6 prompted us to study its mechanism of action. To show that it is mediated through type II photo-oxidation involving singlet oxygen, 14 mixtures of Ab and Ce6 were photoirradiated in the presence of singlet oxygen quenchers, such as His and NaN 3 , and analyzed by SDS-PAGE (Fig. S2a , † compare lane 3 to lanes 4 and 5). Addition of His and NaN 3 to the solution of Ab and Ce6 prior to photoirradiation reduced the cross-linking efficacy of Ce6 (Fig. S2a †) cross links were also conrmed by EPR, using 2,2,6,6-tetramethylpiperidine (TEMP) as a specic spin trap of 1 O 2 (Fig. 2d) . (Fig. S2a †, lane 6) . Together with the signicant inhibitory effect of His (Fig. S2a, † lane 4) , these results strongly suggest that cross-linking of Ab in the presence of Ce6 and light is mediated mainly through His residues. This possibility was further investigated via amino acid analysis, which showed that although photoirradiation of monomeric Ab alone had no effect on its amino acid composition, in the presence of Ce6 it selectively affected the His residues (Table S1 †).
To conrm that the inhibitory effect of photoexcited Ce6 on Ab aggregation is mediated through interaction with, and modication of the Ab His residues, the ThT and dot blot assays were repeated at a pH of 6. We hypothesized that at a pH below the pK a of the His residues, Ce6 will bind Ab weakly, and will thus affect Ab aggregation less while photoirradiated. Thus, Ab was incubated with Ce6 at pH 6, photoirradiated with visible light, and analyzed by ThT and dot blot assays, using the A11 antibody. Fig. 2e shows that while photoirradiation of the Ce6-Ab mixture at pH 7.4 signicantly enhanced the antiamyloidogenic activity, as compared to the dark conditions, it had no effect on Ab aggregation when the incubation was carried out at pH 6. Similarly, the dot blot assay also demonstrated that photoexcited Ce6 is less effective in reducing the amount of toxic Ab oligomers at pH 6 (Fig. 1e, lane 3) . These results indicate that interactions between Ce6 and unprotonated histidines of Ab and their subsequent modications/ cross-linking are at least partially responsible for the antiamyloidogenic activity of Ce6.
Targeting the toxic oligomeric state of amyloidogenic proteins is vital for successful treatment, 3 as many of these proteins, such as amylin and transthyretin exhibit important biological functions when folded correctly. We used SDS-PAGE to show that in contrast to the Ru-mediated PICUP that photo-crosslinks many proteins, Ce6 selectively cross-links Ab via residue-specic binding. Ubiquitin and the Parkinson's disease-associated protein a-synuclein (a-syn) were incubated with Ru 2+ and Ce6, photoirradiated, and analyzed by SDS-PAGE. While photoirradiation of a-syn and ubiquitin with Ru 2+ induced crosslinking as expected (Fig. 2f, lanes 3 and 6) , photoexcited Ce6 failed to cross-link these proteins under similar conditions (Fig. 2f, lanes 2 and 5) . This suggests that the cross-linking effect of Ce6 on Ab involves specic binding between Ce6 and Ab.
NMR studies
The molecular interactions between Ce6 and Ab were further elucidated using NMR spectroscopy. (Fig. 3a and b , blue peaks). However, clear changes in the NMR spectrum were observed aer photoirradiation of the mixture for 1 h (Fig. 3b, red peaks) . Significant losses of NMR signal intensity were observed for crosspeaks corresponding to the N-terminal Ab residues, e.g. F4, R5, D7, S8, G9, Y10, E11 and V12, indicating the site where Ce6 binds. This is also consistent with the lack of interaction between the 6E10 antibody and the photoirradiated Ab-Ce6 mixture (Fig. 1e) . Similar measurements carried out at pH 5.0 showed no effects on the NMR crosspeaks, neither before nor aer 1 h of light exposure ( Fig. 3c and d register His residues, clearly showed that at the concentrations used, Ab's His residues are affected by Ce6 only aer light exposure (Fig. 3e) . The H13 and H14 residues are more affected than H6, suggesting a major interaction around these two central His residues. Moreover, in agreement with the amino acid analysis (Table S1 †), these NMR results indicate that Y10 in Ab is not affected by photoexcited Ce6 (Fig. 3e) , further suggesting that Ab cross-linking occurs via the His residues. Together, the NMR and amino acid analysis data suggest that Ce6 selectively binds to and damages the N-terminal His residues, while other amino acids such as F4, R5, D7, S8, G9, Y10 and E11 are affected by their proximity to the His residues. It has been suggested that H13 (or H14), R5 and Y10 interact with porphyrin-based heme and are responsible for heme-Ab peroxidase activity. 24 In another study, F19 was found to be vital in Ab-heme binding through p-p interaction with the porphyrin ring, which disrupts Ab aggregation. 25 Notably, in most of these studies, the interaction of Ab with heme involves coordination of the related amino acid side chains with the central metal (Fe 3+ ). Since Ce6 contains no metal, the specic interactions between Ce6 and Ab must depend on mechanisms other than metal coordination.
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Cytoprotecting effect of Ce6 against Ab-induced toxicity Because Ce6 inhibits Ab aggregation and reduces the amounts of toxic oligomers, we next examined whether it can also reduce Ab cell toxicity, in darkness or upon photoexcitation. First, Ab 40 was incubated in the absence or presence of Ce6, either in darkness or photoirradiated for 1 h. Next, the mixtures were further aged for 48 h, to allow Ab aggregation, and then incubated for 48 h with rat pheochromocytoma PC12 cells. Finally, cell viability was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Fig. 4) . Incubation of the cells with 2 days aged Ab (without Ce6) killed about 45% of the cells. Photoirradiation of Ab alone, prior to incubation with cells, had no signicant effect on cell survival. In contrast, incubation of the cells with the photoirradiated Ab-Ce6 mixture (10 mM each) signicantly increased cell survival (p < 0.05), while aged Ab-Ce6 mixture kept in darkness had no effect on cell survival. In control experiments, Ce6 alone (10 mM) had no effect on cell survival, neither in darkness nor following 1 h photoirradiation. The highest protecting effect of Ce6 on Ab's toxicity ($30%) was achieved when Ab (10 mM) was incubated with 10-fold excess of Ce6 and photoirradiated for 1 h. However, at this high Ce6 concentration (100 mM), some toxicity was observed even when the cells were incubated in darkness, suggesting that complexation of Ab with Ce6 reduces the toxicity of both components.
Effect of Ce6 on Ab-Cu 2+ interaction and toxicity
Metal ions and metal homeostasis play a vital role in AD etiology and progression. 27 In particular, Cu and Fe ions bind Ab, modulate its aggregation, and generate ROS that are toxic to neurons.
28 AD plaques contain a variety of metals including redox-active Cu and Fe ions, and the increased levels of these metals in AD brain tissue correlate with AD pathology.
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Monomeric Ab peptides bind metal ions with high affinity at their N-terminal, involving the three histidine residues H6, H13, and H14, which act as specic binding ligands, e.g. for Cu 2+ , Mn 2+ , Pb 4+ and Zn 2+ ions. 30 Moreover, H13 and H14 of Ab have been associated with Ab-mediated ion channel/pore formation and cytotoxicity, and blocking these channels with small peptides or molecules prevented Ca 2+ inux and neurotoxicity.
31
Having demonstrated that Ce6 can selectively bind Ab's H13 and H14 residues and damage them under photoirradiation, we tested whether it can also modulate Cu 2+ binding to Ab and reduce Cu 2+ -induced aggregation and toxicity. A solution of monomeric Ab (5 mM) in HEPES buffer was incubated in darkness with Cu 2+ (1.5 mM) in the absence or presence of Ce6 (0.125 mM), and the extent of aggregation was followed by ThT uo-rescence. Ce6 is known for its capability to chelate metals such as Cu 2+ , and this property has been used to generate probes for PET and MRI diagnostics. 32 Therefore, catalytic amounts of Ce6 were used to rule out the possibility that the anti-aggregation activity of Ce6 derives only from its chelation activity. In the absence of Cu 2+ and under the conditions used (20 mM HEPES, pH 7.4), Ab 40 aggregated with a lag phase of about 24 hours (Fig. 5a ). Co-incubation of Ab (5 mM (Fig. 5a ). (Fig. 6b) , 30b while addition of excess Ce6 to the mixture under dark conditions allowed these crosspeaks to partially re-appear (Fig. 6c) . These results indicate that a high excess of Ce6 is able to remove Cu 2+ ions from Ab via competitive binding. Altogether, our results indicate that photoexcited Ce6 catalytically damages the His residues in the early stage of Ab selfassembly, i.e. before its further aggregation into brils. This is in agreement with the reduced immunoreactivity of the Ab-Ce6 complex to the A11 antibody, the generation of Ab cross-links, and the amino acid analysis results ( Fig. 1 and 2) . The specic Fig. 4 Effect of Ce6 and photoexcited Ce6 on the toxicity of Ab40 to rat pheochromocytoma PC12 cells. Freshly prepared Ab40 (100 mM) was aged for 48 h with Ce6 under either dark or light conditions (100 and 1000 mM) in PBS. The samples were then diluted 10 times in the wells containing 10 000 cells. Cell viability was then determined after 48 h of incubation by MTT. *p < 0.005 compared to the same treatment in darkness and with Ab only. All samples contained 0.25% DMSO, which was found to have no effect on cell survival (100% cell survival). -induced Ab aggregation and toxicity. (a) Monomeric Ab (5 mM) was incubated in the dark with Cu 2+ (1.5 mM) in the absence or presence of a catalytic amount of Ce6 (0.125 mM) in HEPES buffer (50 mM, 160 mM NaCl, pH 7.4), and the extent of amyloid formation was monitored over time using the ThT fluorescence. (b) Ce6 counters the effect of Cu 2+ on Ab-induced PC12 toxicity. Ab (10 mM) was aged for 48 h with Cu 2+ in absence or presence of increasing amounts of Ce6 and exposed to PC12 cells for a further 4 days. Cell viability was then determined by the MTT assay. All samples contained 0.25% of DMSO, which was found to be harmless (100% cell survival). The results are presented as mean AE SD of two experiments (n ¼ 3-5 each). Significance (*,**p < 0.05) were calculated relative to Ab 40 (10 mM) on Ab aggregation via competitive binding (Fig. 6 ).
The specic targeting of Ce6 to Ab, rather than to a-synuclein for instance, is noteworthy. Most amyloid proteins aggregate into similar cross-b structures, which is why they are oen able to cross-seed each other's aggregation. 34 Thus, many natural and designed amyloid-inhibiting molecules, such as b-sheet breakers, affect a wide range of amyloid proteins. 2b,20,35 The specicity of Ce6 for Ab is arguably related to the interaction with the three N-terminal Ab histidines, which separate Ab from other amyloid proteins and confer important functionality: in addition to coordinating metal ion binding, 30 they are also required for Ab oligomer formation. 36 As the N-terminal segment is known to be dangling outside when Ab interacts with cell membranes, 28b we expect that Ce6 will be able to target Ab not only in solution, but also in membrane environments. Thus, one important nding of this study is that the three Ab histidines are a suitable target when developing Ab-specic anti-amyloidogenic drugs.
Conclusion
In the present study, we have shown that Ce6 potently inhibits the aggregation and toxicity of Ab under dark conditions, while irradiation with visible light signicantly enhanced its antiamyloidogenic activity. Taken together, our CD, NMR, amino acid analysis, and immunochemical studies using the oligomerspecic A11 antibody indicate that photoexcited Ce6 dramatically delays the formation of Ab b-sheet structures that are reactive to the A11 antibody, by binding to and damaging the Ab N-terminal segment. SDS/PAGE analysis revealed that Ce6 selectively cross-links Ab monomers without affecting other proteins such as a-synuclein or ubiquitin. The Ab cross-linking most likely originates from singlet oxygen generation by lightexposed Ce6, as shown by the EPR studies. The ThT and NMR experiments carried out at neutral and acidic pH show that the N-terminal histidines, especially H13 and H14, are the Ab residues mostly affected by the photoexcited Ce6. We speculate that by binding and damaging the His residues that are responsible for Cu 2+ binding and Cu-induced channel/nanopore formation, 31b,37 catalytic amounts of photoexcited Ce6 can inhibit Cu-induced Ab aggregation and toxicity. However, at high concentrations, Ce6 can either compete with Cu 2+ to bind Ab or act as a chelator to reduce the local concentration of Cu, as shown by the NMR studies. By selective binding to Ab, Ce6 acts as a multifunctional agent that can both damage Ab and remove toxic Cu. While further studies are required in AD animal models to assess the potential clinical applications of Ce6, the specic targeting of Ce6 to the Ab His residues, and not the cross-b sheet structure present in many amyloid aggregates, shows that the three N-terminal histidines are a promising target for Ab-specic anti-amyloidogenic drugs.
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